These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 7958469)

  • 21. Expression of a Porphyromonas gingivalis hemagglutinin on the surface of a Salmonella vaccine vector.
    Isoda R; Simanski SP; Pathangey L; Stone AE; Brown TA
    Vaccine; 2007 Jan; 25(1):117-26. PubMed ID: 16942819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice.
    Kuhöber A; Pudollek HP; Reifenberg K; Chisari FV; Schlicht HJ; Reimann J; Schirmbeck R
    J Immunol; 1996 May; 156(10):3687-95. PubMed ID: 8621903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice.
    Huang Z; Santi L; LePore K; Kilbourne J; Arntzen CJ; Mason HS
    Vaccine; 2006 Mar; 24(14):2506-13. PubMed ID: 16417953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The core antigen of hepatitis B virus as a carrier for immunogenic peptides.
    Murray K; Shiau AL
    Biol Chem; 1999 Mar; 380(3):277-83. PubMed ID: 10223329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
    Shiau AL; Murray K
    J Med Virol; 1997 Mar; 51(3):159-66. PubMed ID: 9139078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Enhancement by an in vivo-activated promoter of immunogenicity of recombinant attenuated Salmonella typhimurium expressing hepatitis C virus core antigen].
    Zhao P; Ke S; Wang HW; Qian F; Qi ZT
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Mar; 35(3):266-70. PubMed ID: 12621552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
    Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Humoral and cellular immunogenecity of genetic vaccine on core gene of hepatitis B virus in mice].
    Huang Z; Lu S; Liu N
    Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):456-9. PubMed ID: 11715443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative immunogenicity of M. hyopneumoniae NrdF encoded in different expression systems delivered orally via attenuated S. typhimurium aroA in mice.
    Chen AY; Fry SR; Forbes-Faulkner J; Daggard GE; Mukkur TK
    Vet Microbiol; 2006 May; 114(3-4):252-9. PubMed ID: 16426773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immune responses of a recombined live Salmonella typhimurium SL3261 expressing a multi-epitope antigen of HCV].
    Huang J; Xie Y; Zhang Q; Shen X; Ren D
    Wei Sheng Wu Xue Bao; 2000 Oct; 40(5):495-9. PubMed ID: 12548760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavior of a short preS1 epitope on the surface of hepatitis B core particles.
    Borisova G; Borschukova O; Skrastina D; Dislers A; Ose V; Pumpens P; Grens E
    Biol Chem; 1999 Mar; 380(3):315-24. PubMed ID: 10223334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen.
    Londoño LP; Chatfield S; Tindle RW; Herd K; Gao XM; Frazer I; Dougan G
    Vaccine; 1996 Apr; 14(6):545-52. PubMed ID: 8782354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hepatitis B virus core protein as an epitope vaccine carrier: a review].
    Yin Y; Xu J; Chen W
    Sheng Wu Gong Cheng Xue Bao; 2010 Apr; 26(4):431-8. PubMed ID: 20575429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus core protein fused to hepatitis B virus core antigen for serological diagnosis of both hepatitis C and hepatitis B infections by ELISA.
    Wu CL; Leu TS; Chang TT; Shiau AL
    J Med Virol; 1999 Feb; 57(2):104-10. PubMed ID: 9892392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative immunogenicity of the hepatitis B virus core 149 antigen displayed on the inner and outer membrane of bacterial ghosts.
    Jechlinger W; Haller C; Resch S; Hofmann A; Szostak MP; Lubitz W
    Vaccine; 2005 May; 23(27):3609-17. PubMed ID: 15855021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of incompatible plasmids to control expression of antigen by Salmonella typhimurium and analysis of immunogenicity in mice.
    Ervin SE; Small PA; Gulig PA
    Microb Pathog; 1993 Aug; 15(2):93-101. PubMed ID: 8255210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Principal neutralizing domain of HIV-1 is highly immunogenic when expressed on the surface of hepatitis B core particles.
    von Brunn A; Brand M; Reichhuber C; Morys-Wortmann C; Deinhardt F; Schödel F
    Vaccine; 1993; 11(8):817-24. PubMed ID: 7689283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deletion modification enhances anthrax specific immunity and protective efficacy of a hepatitis B core particle-based anthrax epitope vaccine.
    Yin Y; Zhang S; Cai C; Zhang J; Dong D; Guo Q; Fu L; Xu J; Chen W
    Immunobiology; 2014 Feb; 219(2):97-103. PubMed ID: 24054942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phage displayed HBV core antigen with immunogenic activity.
    Bahadir AO; Balcioglu BK; Uzyol KS; Hatipoglu I; Sogut I; Basalp A; Erdag B
    Appl Biochem Biotechnol; 2011 Dec; 165(7-8):1437-47. PubMed ID: 21915589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.